Korea regulator fines Samsung BioLogics, wants CEO fired

South Korea ’s top financial regulator said Samsung BioLogics had intentionally breached accounting rules ahead of its 2016 listing, leading to a suspension in trading of the biotech’s shares, a review of its listing status and the request that the CEO is fired.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news